AsianScientist (Jan. 21, 2013) – Actis, a private equity firm investing exclusively in Asia, Africa, and Latin-America, has made a significant minority investment in Nanjing Micro-Tech, a manufacturer of specialist medical equipment to both Chinese and international hospitals and surgeries.
Nanjing Micro-Tech was founded in 2000 and has since grown to become the largest local player in the Chinese endoscopy consumable sector. It also has the leading market position in non-vascular stents and disposable biopsy forceps in China.
“Nanjing Micro-Tech is the number one domestic player in the Chinese endoscopy consumable market; it has built up a loyal following of doctors thanks to the consistently high quality of its products, the reach of its distribution base and its record of innovation,” said Meng Ann Lim, Head of China and South East Asia at Actis.
“Nanjing Micro-Tech has grown steadily over the last 12 years. We are very proud of the reputation we have built and the faith doctors and patients place in our products. Our partnership with Actis will take us to the next stage, equipping us with a clearer strategy, a world-class management team, and new routes of business expansion,” said Derong Leng, CEO and co-founder of Nanjing Micro-Tech.
The global endoscopy consumable sector was a US$4.4 billion market in 2011 and is expected to reach US$7.6 billion in 2017 with 9.4 percent CAGR, says Actis.
——
Source: Actis.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
